This Sexually Transmitted Diseases Cooperative Research Center will emphasize prevention of selected STDs and the consequences of STDs. In particular we are stressing STDs which have significant adverse impact on the health of women. With this approach we will identify ways in which the burden of complications associated with STDs that disproportionately result in adverse effects on the reproductive health of women can be reduced. To achieve this goal we will be taking several approaches. Two intervention studies, an indirect and direct approach will be undertaken to prevent acquisition of bacterial vaginosis (BV), chlamydia and herpes and thereby the complications associated with these STDs. In a biologic intervention approach use of a Lactobacillus capsule will be assessed in a double-blinded placebo-controlled trial to prevent infection with BV, C. trachomatis, and other genital infections. By studying the stigma associated with herpes and developing an intervention designed to produce more rational herpes-related decision making we are attempting to prevent acquisition pf HSV. Determining the antimicrobial protective function of secretory leukocyte protease inhibitor (SI PI) will add to our knowledge understanding of the biologic interaction between T. vaginalis and HIV and other STDs; it also may lead to innovative vaginal microbicidal strategies. Determining the molecular mechanisms of gonococcal iron acquisition and the expression and immunogenecity of iron acquisition will provide information relevant to developing gonococcal vaccines based on the human transferrin-binding protein complex and pathogen-targeted antimicrobial interventions targeting the iron-acquisition mechanism of N. gonorrhea. This STD CRC proposal integrates clinical, epidemiological, behavioral and fundamental research into a collaborative effort by investigators from Ob/Gyn, Medicine, Infectious Diseases, Microbiology, Immunology, Behavioral Sciences and Epidemiology that addresses the disproportionate burden of the STD epidemic that affects women.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI047785-04
Application #
6374548
Study Section
Special Emphasis Panel (ZAI1-ALR-M (01))
Program Officer
Savarese, Barbara M
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2004-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$620,410
Indirect Cost
Name
Magee-Women's Research Institute and Foundation
Department
Type
DUNS #
058625146
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Cook, Robert L; Downs, Julie S; Marrazzo, Jeanne et al. (2009) Preferred characteristics of vaginal microbicides in women with bacterial vaginosis. J Womens Health (Larchmt) 18:1163-7
Bunge, Katherine E; Beigi, Richard H; Meyn, Leslie A et al. (2009) The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis 36:711-3
Antonio, May A D; Meyn, Leslie A; Murray, Pamela J et al. (2009) Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis 199:1506-13
Beigi, Richard H; Yudin, Mark H; Cosentino, Lisa et al. (2007) Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis 196:1355-60
Marrazzo, Jeanne M; Wiesenfeld, Harold C; Murray, Pamela J et al. (2006) Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 193:617-24
Marrazzo, Jeanne M; Cook, Robert L; Wiesenfeld, Harold C et al. (2006) Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health (Larchmt) 15:1053-60
Kwok, Louisa; Stapleton, Ann E; Stamm, Walter E et al. (2006) Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. J Urol 176:2050-4; discussion 2054
Austin, M N; Beigi, R H; Meyn, L A et al. (2005) Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 43:4492-7
Antonio, May A D; Rabe, Lorna K; Hillier, Sharon L (2005) Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 192:394-8
Beigi, Richard H; Austin, Michele N; Meyn, Leslie A et al. (2004) Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191:1124-9

Showing the most recent 10 out of 15 publications